• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。

Herd immunization with childhood vaccination may provide protection against COVID-19.

机构信息

1Mindong Hospital, Fuan, Ningde, China.

2The Affiliated Mindong Hospital of Fujian Medical University, Fuan, Ningde, China.

出版信息

Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.

DOI:10.1556/030.2020.01207
PMID:32986604
Abstract

It may take time to obtain a vaccine for the current COVID-19, and the virus genome may keep an evolution and mutations, so a universal and effective vaccine for the coronavirus may not be possible. Epidemiological studies reveal the infection of SARS and COVID-19 in children is less frequent and less severe than in adults. Childhood vaccine-mediated cross cellular immunity and immunomodulation might provide protection against the infections of COVID-19. These data suggest that herd immunization with children vaccines in adults may improve the adult cross cellular immunity and immunomodulation and improve their clinical presentation and prognosis. This can be also useful to cope with future pandemics.

摘要

目前针对 COVID-19 的疫苗可能需要时间研发,且病毒基因组可能会不断进化和变异,因此针对冠状病毒的通用且有效的疫苗可能无法实现。流行病学研究表明,儿童感染 SARS 和 COVID-19 的频率和严重程度低于成人。儿童疫苗介导的跨细胞免疫和免疫调节可能为 COVID-19 的感染提供保护。这些数据表明,在成人中使用儿童疫苗进行群体免疫可能会改善成人的跨细胞免疫和免疫调节,并改善他们的临床表现和预后。这对于应对未来的大流行也可能是有用的。

相似文献

1
Herd immunization with childhood vaccination may provide protection against COVID-19.群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。
Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.
2
[Immunity against SARS-CoV-2: walking to the vaccination].[对严重急性呼吸综合征冠状病毒2的免疫:迈向疫苗接种之路]
Rev Esp Quimioter. 2020 Dec;33(6):392-398. doi: 10.37201/req/086.2020. Epub 2020 Sep 11.
3
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
4
COVID-19 pandemic and vaccination build herd immunity.新冠疫情及疫苗接种构筑群体免疫。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):577-579. doi: 10.26355/eurrev_202101_24613.
5
Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.韩国针对 SARS-CoV-2 的接触调整免疫水平和实现群体免疫的前景。
J Korean Med Sci. 2021 Oct 4;36(38):e272. doi: 10.3346/jkms.2021.36.e272.
6
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
7
COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.COVID-19 疫苗与群体免疫:观点、挑战与展望。
Malays J Pathol. 2021 Aug;43(2):203-217.
8
One Shot Wonder: A Vaccine Against All Coronaviruses.一次性奇迹:一种针对所有冠状病毒的疫苗。
IEEE Pulse. 2020 Nov-Dec;11(6):2-5. doi: 10.1109/MPULS.2020.3036198.
9
Five reasons why COVID herd immunity is probably impossible.新冠病毒群体免疫可能无法实现的五个原因。
Nature. 2021 Mar;591(7851):520-522. doi: 10.1038/d41586-021-00728-2.
10
Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.基于模型的奥地利 SARS-CoV-2 免疫水平估计及其对群体免疫效果的影响。
Sci Rep. 2022 Feb 21;12(1):2872. doi: 10.1038/s41598-022-06771-x.

引用本文的文献

1
A cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19.卡塔尔开展的一项关于流感疫苗接种对 COVID-19 严重程度影响的横断面研究。
Medicine (Baltimore). 2023 Sep 15;102(37):e35107. doi: 10.1097/MD.0000000000035107.
2
Effect of influenza vaccine on COVID-19 mortality: a retrospective study.流感疫苗对 COVID-19 死亡率的影响:一项回顾性研究。
Intern Emerg Med. 2021 Oct;16(7):1849-1855. doi: 10.1007/s11739-021-02702-2. Epub 2021 Mar 20.